Veterinary Medicines

NOBILIS IB MULTI+ND+EDS ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Authorised
  • Egg drop syndrome '76 virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Download as PDF

Product identification

Medicine name:
NOBILIS IB MULTI+ND+EDS ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Egg drop syndrome '76 virus, Inactivated
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Egg drop syndrome '76 virus, Inactivated
    6.50
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    0.01
    millilitre(s)
  • Avian infectious bronchitis virus, type D274/D207, strain 249g, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    4.00
    log2 virus neutralising unit(s)
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 34517/12-10-1999/K-0126401
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."